• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

菌株竞争对免疫功能低下人群细菌耐药性的影响

Impact of Strain Competition on Bacterial Resistance in Immunocompromised Populations.

作者信息

DeNegre Ashley A, Myers Kellen, Fefferman Nina H

机构信息

Department of Ecology, Evolution and Natural Resources, Rutgers University, New Brunswick, NJ 08901, USA.

The Command, Control and Interoperability Center for Advanced Data Analysis (CCICADA), Rutgers University, New Brunswick, NJ 08901, USA.

出版信息

Antibiotics (Basel). 2020 Mar 7;9(3):114. doi: 10.3390/antibiotics9030114.

DOI:10.3390/antibiotics9030114
PMID:32156072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7148506/
Abstract

Despite the risk of emerging drug resistance that occurs with the frequent use of antimicrobial agents, targeted and prophylactic antibiotics have been considered crucial to opportunistic infection management among the HIV/AIDS-immunocompromised. As we recently demonstrated, the disrupted selective pressures that occur in AIDS-prevalent host populations increase the probability of novel emergence. This effect is concerning, given that bacterial strains unresponsive to first-line antibiotics can be particularly dangerous to hosts whose immune response is insufficient to fight infection in the absence of antibiotic support. While greater host susceptibility within a highly immunocompromised population may offer a fitness advantage to drug-resistant bacterial strains, this advantage could be mitigated by increased morbidity and mortality among the AIDS-immunocompromised. Using a Susceptible-Exposed-Infectious-Recovered (SEIR) epidemiological model parameterized to reflect conditions in an AIDS-prevalent host population, we examine the evolutionary relationship between drug-sensitive and -resistant strains of . We explore this relationship when the fitness of the resistant strain is varied relative to that of the sensitive strain to investigate the likely long-term multi-strain dynamics of the AIDS-mediated increased emergence of drug resistance.

摘要

尽管频繁使用抗菌药物会出现新的耐药风险,但针对性和预防性抗生素一直被认为对于管理艾滋病毒/艾滋病免疫功能低下者的机会性感染至关重要。正如我们最近所证明的,艾滋病流行宿主群体中被打乱的选择压力增加了新菌株出现的可能性。鉴于对一线抗生素无反应的细菌菌株对免疫反应不足以在没有抗生素支持的情况下抵抗感染的宿主可能特别危险,这种影响令人担忧。虽然在高度免疫功能低下的人群中宿主易感性增加可能会给耐药细菌菌株带来适应性优势,但这种优势可能会因艾滋病免疫功能低下者发病率和死亡率的增加而减弱。我们使用一个易感-暴露-感染-康复(SEIR)流行病学模型,该模型经过参数化以反映艾滋病流行宿主群体中的情况,来研究[具体细菌名称]的药敏菌株和耐药菌株之间的进化关系。当耐药菌株的适应性相对于敏感菌株有所变化时,我们探究这种关系,以研究艾滋病介导的耐药性增加出现的可能长期多菌株动态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d35/7148506/81c1448efba1/antibiotics-09-00114-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d35/7148506/9502fa4be0e5/antibiotics-09-00114-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d35/7148506/74e80a355d2a/antibiotics-09-00114-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d35/7148506/eea6b3aeb273/antibiotics-09-00114-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d35/7148506/d7830a6d7a2a/antibiotics-09-00114-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d35/7148506/81c1448efba1/antibiotics-09-00114-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d35/7148506/9502fa4be0e5/antibiotics-09-00114-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d35/7148506/74e80a355d2a/antibiotics-09-00114-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d35/7148506/eea6b3aeb273/antibiotics-09-00114-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d35/7148506/d7830a6d7a2a/antibiotics-09-00114-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d35/7148506/81c1448efba1/antibiotics-09-00114-g005.jpg

相似文献

1
Impact of Strain Competition on Bacterial Resistance in Immunocompromised Populations.菌株竞争对免疫功能低下人群细菌耐药性的影响
Antibiotics (Basel). 2020 Mar 7;9(3):114. doi: 10.3390/antibiotics9030114.
2
Emergence of antibiotic resistance in immunocompromised host populations: A case study of emerging antibiotic resistant tuberculosis in AIDS patients.免疫功能低下宿主人群中抗生素耐药性的出现:以艾滋病患者中新兴抗生素耐药性肺结核为例。
PLoS One. 2019 Feb 28;14(2):e0212969. doi: 10.1371/journal.pone.0212969. eCollection 2019.
3
Impact of chemorophylaxis policy for AIDS-immunocompromised patients on emergence of bacterial resistance.艾滋病免疫功能低下患者化学预防政策对细菌耐药性出现的影响。
PLoS One. 2020 Jan 30;15(1):e0225861. doi: 10.1371/journal.pone.0225861. eCollection 2020.
4
Tuberculosis结核病
5
[Tuberculosis in compromised hosts].[免疫功能低下宿主中的结核病]
Kekkaku. 2003 Nov;78(11):717-22.
6
Models to understand the population-level impact of mixed strain M. tuberculosis infections.用于了解混合结核分枝杆菌感染对人群影响的模型。
J Theor Biol. 2011 Jul 7;280(1):88-100. doi: 10.1016/j.jtbi.2011.04.011. Epub 2011 Apr 16.
7
RelA Mutant Enterococcus faecium with Multiantibiotic Tolerance Arising in an Immunocompromised Host.在免疫功能低下宿主中出现的具有多种抗生素耐受性的RelA突变粪肠球菌
mBio. 2017 Jan 3;8(1):e02124-16. doi: 10.1128/mBio.02124-16.
8
The theoretical influence of immunity between strain groups on the progression of drug-resistant tuberculosis epidemics.菌株组间免疫对耐药结核病流行进程的理论影响。
J Infect Dis. 2008 Nov 15;198(10):1502-13. doi: 10.1086/592508.
9
Bacteremic pneumococcal infections in immunocompromised patients without AIDS: the impact of beta-lactam resistance on mortality.无艾滋病免疫功能低下患者的菌血症性肺炎球菌感染:β-内酰胺耐药性对死亡率的影响。
Int J Infect Dis. 2003 Mar;7(1):46-52. doi: 10.1016/s1201-9712(03)90042-7.
10
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.

引用本文的文献

1
Enzyme-Linked Lipid Nanocarriers for Coping Pseudomonal Pulmonary Infection. Would Nanocarriers Complement Biofilm Disruption or Pave Its Road?酶联脂质纳米载体应对铜绿假单胞菌肺部感染。纳米载体是补充生物膜破坏还是为其铺平道路?
Int J Nanomedicine. 2024 Apr 29;19:3861-3890. doi: 10.2147/IJN.S445955. eCollection 2024.
2
Synthesis, Antibacterial and Anthelmintic Activity of Novel 3-(3-Pyridyl)-oxazolidinone-5-methyl Ester Derivatives.新型 3-(3-吡啶基)-恶唑烷酮-5-甲酯衍生物的合成、抑菌和驱虫活性。
Molecules. 2022 Feb 7;27(3):1103. doi: 10.3390/molecules27031103.
3
Antibiotics and Environment.

本文引用的文献

1
Impact of chemorophylaxis policy for AIDS-immunocompromised patients on emergence of bacterial resistance.艾滋病免疫功能低下患者化学预防政策对细菌耐药性出现的影响。
PLoS One. 2020 Jan 30;15(1):e0225861. doi: 10.1371/journal.pone.0225861. eCollection 2020.
2
Emergence of antibiotic resistance in immunocompromised host populations: A case study of emerging antibiotic resistant tuberculosis in AIDS patients.免疫功能低下宿主人群中抗生素耐药性的出现:以艾滋病患者中新兴抗生素耐药性肺结核为例。
PLoS One. 2019 Feb 28;14(2):e0212969. doi: 10.1371/journal.pone.0212969. eCollection 2019.
3
Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events.
抗生素与环境
Antibiotics (Basel). 2020 Apr 23;9(4):202. doi: 10.3390/antibiotics9040202.
伤寒沙门氏菌主要多重耐药H58分支的系统发育地理学分析确定了洲际和洲内传播事件。
Nat Genet. 2015 Jun;47(6):632-9. doi: 10.1038/ng.3281. Epub 2015 May 11.
4
Prevalence of antibiotic resistance in bacteria isolated from drinking well water available in Guinea-Bissau (West Africa).从几内亚比绍(西非)饮用水井中分离出的细菌的抗生素耐药性流行情况。
Ecotoxicol Environ Saf. 2014 Aug;106:188-94. doi: 10.1016/j.ecoenv.2014.04.037. Epub 2014 May 20.
5
Antibiotic resistance-the need for global solutions.抗生素耐药性——全球解决方案的必要性。
Lancet Infect Dis. 2013 Dec;13(12):1057-98. doi: 10.1016/S1473-3099(13)70318-9. Epub 2013 Nov 17.
6
The end of AIDS: HIV infection as a chronic disease.终结艾滋病:HIV 感染即慢性病。
Lancet. 2013 Nov 2;382(9903):1525-33. doi: 10.1016/S0140-6736(13)61809-7. Epub 2013 Oct 23.
7
Recent patterns in population-based HIV prevalence in Swaziland.斯威士兰人群中 HIV 流行率的最新模式。
PLoS One. 2013 Oct 15;8(10):e77101. doi: 10.1371/journal.pone.0077101. eCollection 2013.
8
Understanding physician antibiotic prescribing behaviour: a systematic review of qualitative studies.理解医生开具抗生素处方行为:定性研究的系统评价。
Int J Antimicrob Agents. 2013 Mar;41(3):203-12. doi: 10.1016/j.ijantimicag.2012.09.003. Epub 2012 Nov 3.
9
The evolving epidemiology of HIV/AIDS.HIV/AIDS 流行病学的演变。
AIDS. 2012 Jun 19;26(10):1205-13. doi: 10.1097/QAD.0b013e328354622a.
10
Challenges of drug resistance in the developing world.发展中世界的耐药性挑战。
BMJ. 2012 Apr 3;344:e1567. doi: 10.1136/bmj.e1567.